Exact Mass: 895.4327136
Exact Mass Matches: 895.4327136
Found 28 metabolites which its exact mass value is equals to given mass value 895.4327136
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Globulin G
C36H61N7O19 (895.4022035999999)
Biie-0246
C49H57N11O6 (895.4493061999999)
5-(diaminomethylideneamino)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[[2-[1-[2-oxo-2-[4-(6-oxo-5,11-dihydrobenzo[c][1]benzazepin-11-yl)piperazin-1-yl]ethyl]cyclopentyl]acetyl]amino]pentanamide
C49H57N11O6 (895.4493061999999)
BIIE-0246
C49H57N11O6 (895.4493061999999)
BIIE-0246 (AR-H 053591) is a potent and selective NPY2R (neuropeptide Y receptor 2) antagonist with an IC50 value of 15 nM for rat [125I]PYY3-36. BIIE-0246 decreases the expression of p-AKT S473, P-p44/42 MAPK under the NPY-stimulated. BIIE-0246 reduces albuminuria in ADR nephropathy[1][2][3].
(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
C40H62ClN9O12 (895.4206241999999)
(2r)-n-[(2s,5s,8s,11r,12s,15s,18r,21r)-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
C40H62ClN9O12 (895.4206241999999)
(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[(1s)-1-{[(3s,7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid
(5r,8s,11r,15s,18s,19s,22r)-3,6,9,13,16,20-hexahydroxy-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,15,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid
(5r,8s,11r,12s,15s,18s,19s,22r)-3,6,9,13,16,20-hexahydroxy-8-isopropyl-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,12,15,19-pentamethyl-2-methylidene-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid
n-[9-benzyl-5,8,14,17-tetrahydroxy-6-(1-hydroxyethyl)-3-[({2-[(1-hydroxyethylidene)amino]acetyl}oxy)methyl]-12-(4-methoxyphenyl)-10,19-dimethyl-2,11-dioxo-15-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,13,16-tetraen-18-yl]-2-methylpropanimidic acid
(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
C40H62ClN9O12 (895.4206241999999)
(5r,8s,11r,12s,15s,18s,19s,22r)-3,6,9,13,16,20,25-heptahydroxy-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-5,12,15,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-1,4,7,10,14,17,21-heptaazacyclopentacosa-1(25),3,6,9,13,16,20-heptaene-11,22-dicarboxylic acid
n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
C40H62ClN9O12 (895.4206241999999)
(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[(1s)-1-{[(7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid
{[(10r,11s,12s,14r,16s,20s,21r,22s,24e)-12,22-dihydroxy-10-methoxy-20-[(2s,3s,7e,9s,10e)-2-methoxy-3,7,9-trimethyl-11-(n-methylformamido)-6-oxoundeca-7,10-dien-1-yl]-11,14,21-trimethyl-18-oxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.1²,⁵.1⁶,⁹]hentriaconta-1(28),2(31),4,6(30),8,24,26(29)-heptaen-16-yl]oxy}methanimidic acid
n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
C40H62ClN9O12 (895.4206241999999)